SCHEMBL7777338

SCHEMBL7777338

CC=Cn1nc(-c2ccncc2)c(-c2ccc(S(N)(=O)=O)cc2)c1C(F)(F)F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 10/20 0.53
PTGS1 P23219 5/20 0.53
LRRK2 Q5S007 2/20 0.41
KIF11 P52732 1/20 0.40
CYP2C9 P11712 2/20 0.39
SRC P12931 1/20 0.39
BRAF P15056 1/20 0.39
KDR P35968 1/20 0.39
CA1 P00915 3/20 0.39
CA2 P00918 3/20 0.39
CA12 O43570 2/20 0.39
CA9 Q16790 2/20 0.39
PDPK1 O15530 3/20 0.39
ALOX5 P09917 2/20 0.39
PTGES O14684 1/20 0.39
HDAC3 O15379 1/20 0.39
PDE5A O76074 1/20 0.39
ABCB11 O95342 1/20 0.39
MT-CO2 P00403 1/20 0.39
LMNA P02545 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7773378 1.00 PTGS2 (0.53) PTGS2PTGS1LRRK2KIF11CYP2C9
SCHEMBL7780060 0.90 PTGS2 (0.66) PTGS2PTGS1CA1CA2CA12
SCHEMBL7780102 0.90 PTGS2 (0.54) PTGS2PTGS1CA1CA2CA12
SCHEMBL7773256 0.90 PTGS2 (0.54) PTGS2PTGS1CYP2C9CA1CA2
SCHEMBL7772916 0.90 PTGS2 (0.53) PTGS2PTGS1ALOX5MAPK14
SCHEMBL7777671 0.90 PTGS2 (0.53) PTGS2PTGS1ALOX5MAPK14
SCHEMBL7773180 0.89 PTGS2 (0.53) PTGS2PTGS1CA1CA2CA12
SCHEMBL7780007 0.87 PTGS2 (0.52) PTGS2PTGS1CA1CA2CA12
SCHEMBL7780765 0.87 PTGS2 (0.52) PTGS2PTGS1CYP2C9CA1CA2
SCHEMBL7779636 0.83 PTGS2 (0.50) PTGS2PTGS1KIF11CYP2C9CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP disclosed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO disclosed